Converge Bio

Wilmington, United States

Converge Bio integrates Generative AI with biological data.

$25.0M raised

Jan 2026

Series A

Top Investors

Bessemer Venture PartnersTLV PartnersVintage Investment PartnersSaras CapitalAuroraAxis Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Converge Bio raised?

Converge Bio has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Converge Bio's investors?

Converge Bio's investors include Bessemer Venture Partners, TLV Partners, Vintage Investment Partners, Saras Capital, AuroraAxis Capital.

Where is Converge Bio headquartered?

Converge Bio is headquartered in Wilmington, United States.

What does Converge Bio do?

Converge Bio integrates Generative AI with biological data.

What stage is Converge Bio at?

Converge Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 13, 2026.

MLA

"Converge Bio — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/converge-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Converge Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/converge-bio

Wikipedia (cite web)

{{cite web |title=Converge Bio — Funding & Investors |url=https://www.vcbacked.co/company/converge-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 13, 2026.